H1N1 influenza A vaccine (split virion, inactivated), Hualan Biological Engineering

甲型H1N1流感病毒裂解疫苗（华兰生物疫苗有限公司）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameH1N1 influenza A vaccine (split virion, inactivated), Hualan Biological Engineering
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Inactivated vaccine > Split vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRespiratory Tract DiseasesOrthomyxoviridae InfectionsVirus Diseases +[5] 
Global Approved IndicationsInfluenza, Human
Approved Indications in ChinaInfluenza, Human
Original Approved Country/TerritoryMainland China
Original Approved Date2009/09/04
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesHualan Biological Bacterin Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHualan Biological Bacterin Co Ltd
Inactive CompaniesHualan Biological Engineering Inc
Active IndicationsInfluenza, Human
Inactive IndicationsRespiratory Tract DiseasesOrthomyxoviridae InfectionsVirus Diseases +[4] 

Other Information

ATC CodeJ07BB02
Related LinksN/A